myristic acid has been researched along with Osteosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holt, JT; Jotte, RM | 1 |
| Masellis-Smith, A; Seehafer, JG; Shaw, AR; Slupsky, JR; Tang, SC | 1 |
2 other study(ies) available for myristic acid and Osteosarcoma
| Article | Year |
|---|---|
Myristylation of FBR v-fos dictates the differentiation pathways in malignant osteosarcoma.
Topics: 3T3 Cells; Animals; Base Sequence; Cell Differentiation; Cell Transformation, Neoplastic; Mice; Mice, Inbred BALB C; Mice, Transgenic; Moloney murine leukemia virus; Myristic Acid; Myristic Acids; Oncogene Proteins v-fos; Osteosarcoma; Polymerase Chain Reaction; Protein Processing, Post-Translational; Repetitive Sequences, Nucleic Acid; Sarcoma Viruses, Murine | 1996 |
Myristic acid is incorporated into the two acylatable domains of the functional glycoprotein CD9 in ester, but not in amide bonds.
Topics: Acylation; Amides; Antigens, CD; Antigens, Differentiation; Cell Line; Esters; Humans; Kinetics; Leucine; Membrane Glycoproteins; Myristic Acid; Myristic Acids; Osteosarcoma; Palmitic Acid; Palmitic Acids; Radioisotope Dilution Technique; Tetraspanin 29; Tritium | 1990 |